The thing is, yes, it might be a while before they are generating profits, however as they have explained each $1 million of inventory spend can generate $2 million of cash for the Company over 12 months. This will get faster as their level of stock turnover increases, thus product demand is key.
Therefore, if all goes to plan there should not be a need for capital raising's as this isn't some biotech company, in which we're betting on a trial result, the formula has already been proven. They have stated that they are now fully stocked and looking at their recent announcement $395,496 in inventory and $1,279,993 in prepayments, that should equate, according to their working example, to $3,350,978 in cash receipts that is yet to be received. Then you factor in the future RMR from selling all that inventory. Assuming my figures are far too optimistic, anything close to their working example as stated in January Update makes this company a promising bet in an intriguing growth market.
- Forums
- ASX - By Stock
- SCT
- Conference Call
Conference Call, page-7
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.627M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
SCT (ASX) Chart |
Day chart unavailable
The Watchlist
ATC
ALTECH BATTERIES LTD
Martin Stein, CFO
Martin Stein
CFO
Previous Video
Next Video
SPONSORED BY The Market Online